Caribou Biosciences (CRBU) News
NASDAQ: CRBUHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
0.4602-0.021 (-4.36%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
CRBU news summary
We found 3 recent headlines mentioning Caribou Biosciences (CRBU): 2 in the past week and 2 in the past 30 days, most often from Nasdaq. For price context, CRBU is down 4.36% at $0.4602. The most recent story, "Weekly Buzz: RHHBY, NVS, PFE Win FDA Nod; CRBU Scales Back; PCVX, ABBV Report Positive Trial Data", was published by Nasdaq on Oct 9, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Caribou Biosciences headlines
- Weekly Buzz: RHHBY, NVS, PFE Win FDA Nod; CRBU Scales Back; PCVX, ABBV Report Positive Trial Data(RTTNews) - This week, biopharmaceutical companies saw a busy week of regulatory decisions, strategic partnerships and clinical developments, alongside pipeline setbacks and workforce reductions.NasdaqABBV, ALVO, ARGX, BBIO
- Thursday Sector Laggards: Biotechnology, Packaging & ContainersIn trading on Thursday, biotechnology shares were relative laggards, down on the day by about 2.4%. Helping drag down the group were shares of Caribou Biosciences, down about 19.3% and shares of…NasdaqCRBU, RXRX, ORBS, PACK
- Here's Why You Should Retain IQVIA Stock in Your Portfolio NowIQV shares rise 21.7% in a month as data assets, AI-enabled technology and strong cash flow support growth despite liquidity and pricing risks.NasdaqIQV, GMED, CRBU